Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV)
US8329396B1 · kind B1 · utility
4Cited by
8References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 27, 1993 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Apr 27, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16022
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention is in the field of lymphadenopathy virus. This invention relates to a diagnostic means and method of detecting lymphadenopathy associated virus or related viruses or DNA pro-viruses with cloned DNA sequences which are hybridizable to genomic RNA and DNA of lymphadenopathy associated virus. It further relates to the cloned DNA sequences and a process for their preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.